Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Jan;19(1):110–113. doi: 10.1128/aac.19.1.110

Liquid chromatographic assay of ketoconazole.

F A Andrews, L R Peterson, W H Beggs, D Crankshaw, G A Sarosi
PMCID: PMC181366  PMID: 6264840

Abstract

A reverse-phase, high-pressure liquid chromatographic method for the rapid and quantitative determination of ketoconazole has been developed. Drug levels from 0.5 to 10 microgram/ml can be determined in either yeast nitrogen base medium or human serum by using an octadecylsilane column. A retention time of 4.9 +/- 0.1 min resulted when the drug was eluted from a column with 75% methanol-25% 0.02 M (pH 7.5) phosphate buffer at a flow rate of 2 ml/min. Optimum sensitivity was obtained at a wavelength of 231 nm.

Full text

PDF
110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews F. A., Beggs W. H., Sarosi G. A. Influence of antioxidants on the bioactivity of amphotericin B. Antimicrob Agents Chemother. 1977 Apr;11(4):615–618. doi: 10.1128/aac.11.4.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blair A. D., Forrey A. W., Meijsen B. T., Cutler R. E. Assay of flucytosine and furosemide by high-pressure liquid chromatography. J Pharm Sci. 1975 Aug;64(8):1334–1339. doi: 10.1002/jps.2600640816. [DOI] [PubMed] [Google Scholar]
  3. Borelli D., Bran J. L., Fuentes J., Legendre R., Leiderman E., Levine H. B., Restrepo A., Stevens D. A. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgrad Med J. 1979 Sep;55(647):657–661. doi: 10.1136/pgmj.55.647.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Diasio R. B., Wilburn M. E., Shadomy S., Espinel-Ingroff A. Rapid determination of serum 5-fluorocytosine levels by high-performance liquid chromatography. Antimicrob Agents Chemother. 1978 Mar;13(3):500–504. doi: 10.1128/aac.13.3.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Heeres J., Backx L. J., Mostmans J. H., Van Cutsem J. Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J Med Chem. 1979 Aug;22(8):1003–1005. doi: 10.1021/jm00194a023. [DOI] [PubMed] [Google Scholar]
  6. Levine H. B., Cobb J. M. Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole. Am Rev Respir Dis. 1978 Oct;118(4):715–721. doi: 10.1164/arrd.1978.118.4.715. [DOI] [PubMed] [Google Scholar]
  7. Nilsson-Ehle I., Yoshikawa T. T., Edwards J. E., Schotz M. C., Guze L. B. Quantitation of amphotericin B with use of high-pressure liquid chromatography. J Infect Dis. 1977 Mar;135(3):414–422. doi: 10.1093/infdis/135.3.414. [DOI] [PubMed] [Google Scholar]
  8. Odds F. C., Milne L. J., Gentles J. C., Ball E. H. The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole. J Antimicrob Chemother. 1980 Jan;6(1):97–104. doi: 10.1093/jac/6.1.97. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES